Literature DB >> 9065977

Behaviorally induced reproductive compromise in women and men.

S L Berga1.   

Abstract

Behaviors that activate the hypothalamic-pituitary-adrenal (HPA) axis or suppress the hypothalamic-pituitary-thyroidal (HPT) axis can disrupt the hypothalamic-pituitary-gonadal (HPG) axis in women and men. Individuals with functional hypothalamic hypogonadism typically display a combination of behaviors that serve as psychogenic stressors and metabolic challenges. Complete recovery of gonadal function depends upon restoration of the HPA and HPT axes. Hormone replacement strategies have limited benefit, because they do not achieve this objective and they mask deficits that accrue from altered HPA and HPT function. Although fertility can be restored with exogenous administration of gonadotropins or pulsatile gonadoropin-releasing hormone (GnRH), fertility management alone will not permit the HPA and HPT axes to recover. Thus, for complete recovery to ensue, biopsychosocial interventions that address the individual's unique set of psychogenic factors and metabolic challenges must be devised.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065977     DOI: 10.1055/s-2008-1067967

Source DB:  PubMed          Journal:  Semin Reprod Endocrinol        ISSN: 0734-8630


  2 in total

1.  Psychopathological traits of adolescents with functional hypothalamic amenorrhea: a comparison with anorexia nervosa.

Authors:  Monica Bomba; Fabiola Corbetta; Luisa Bonini; Alessandro Gambera; Lucio Tremolizzo; Francesca Neri; Renata Nacinovich
Journal:  Eat Weight Disord       Date:  2013-08-04       Impact factor: 4.652

2.  Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).

Authors:  Bina Ahmed; C Noel Bairey Merz; B Delia Johnson; Vera Bittner; Sarah L Berga; Glenn D Braunstein; T Keta Hodgson; Karen Smith; Leslee Shaw; Sheryl F Kelsey; George Sopko
Journal:  Am J Cardiol       Date:  2008-05-09       Impact factor: 2.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.